Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 2, 2012, Pages 141-151

  Sostres, Carlos ^a,b   Gargallo, Carla J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Gastrointestinal bleeding; Low dose aspirin; Mortality; Time trends

Indexed keywords

ACETYLSALICYLIC ACID; BICARBONATE; CALGRANULIN; CLOPIDOGREL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2;

ACUTE CORONARY SYNDROME; AGE DISTRIBUTION; ARTICLE; BLEEDING; CAPSULE ENDOSCOPY; CLINICAL PRACTICE; COMORBIDITY; DIGESTIVE SYSTEM INJURY; DYSPEPSIA; ECCHYMOSIS; ENZYME INHIBITION; EPITHELIUM CELL; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HUMAN; HYDROPHOBICITY; HYPOALBUMINEMIA; IRON DEFICIENCY ANEMIA; LIPOPHILICITY; LOW DRUG DOSE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PETECHIA; PROSTAGLANDIN BLOOD LEVEL; SIDE EFFECT; STOMACH INJURY; STOMACH MUCOSA; STOMACH PERFORATION; STOMACH PH; TRANSIENT ISCHEMIC ATTACK; ULCER PERFORATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TRACT; HUMANS; LOWER GASTROINTESTINAL TRACT; PEPTIC ULCER; UPPER GASTROINTESTINAL TRACT;

EID: 84860237358     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.01.016     Document Type: Article

References (78)

1. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, and R. Peto Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
2. U.A. Ajani, E.S. Ford, K.J. Greenland, W.H. Giles, and A.H. Mokdad Aspirin use among U.S. adults: behavioral risk factor Surveillance system Am J Prev Med 1 2006 74 77
3. National Health Service Information Centre Prescription cost analysis for England 2007 2008 Available at: http://www.ic.nhs.uk/webfiles/publications/ PCA%20publication/PCA%202007%20complete%20V2.pdf [accessed 21.10.11]
4. J. Weil, D. Colin-Jones, M. Langman, D. Lawson, R. Logan, and M. Murphy Prophylactic aspirin and risk of peptic ulcer bleeding BMJ 310 1995 827 830
5. N.D. Yeomans, A.I. Lanas, N.J. Talley, A.B. Thomson, R. Daneshjoo, and B. Eriksson Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin Aliment Pharmacol Ther 22 2005 795 801
6. D.L. Bhatt, J. Scheiman, N.S. Abraham, E.M. Antman, F.K. Chan, and C.D. Furberg ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 52 2008 1502 1517
7. A. Lanas Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice Expert Opin Drug Saf 10 1 2011 Jan 45 54
8. G. Cayla, J.P. Collet, J. Silvain, G. Thiefin, F. Woimant, and G. Montalescot Prevalence and clinical impact of upper gastrointestinal symptoms in subjects treated with low dose aspirin: the UGLA survey Int J Cardiol 2010 Nov 17
9. L.A. García Rodríguez, L. Cea Soriano, E. Martín-Merino, and S. Johansson Discontinuation of low-dose acetylsalicylic acid treatment for secondary prevention of cardiovascular outcomes Circulation 120 2009 S480
10. J.P. Collet, G. Montalescot, B. Blanchet, M.L. Tanguy, J.L. Golmard, and R. Choussat Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes Circulation 110 2004 2361 2367
11. A.B. Maulaz, D.C. Bezerra, P. Michel, and J. Bogousslavsky Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke Arch Neurol 62 2005 1217 1220
12. G.G. Biondi-Zoccai, M. Lotrionte, P. Agostoni, A. Abbate, M. Fusaro, and F. Burzotta A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease Eur Heart J 27 2006 2667 2674
13. L.A. Rodríguez, L. Cea-Soriano, E. Martín-Merino, and S. Johansson Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care BMJ 343 2011 Jul 19 d4094 10.1136/bmj.d4094
14. G. Holtmann, J. Gschossmann, L. Buenger, G. Gerken, and N.J. Talley Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology 123 5 2002 Nov 1451 1458
15. N.D. Yeomans Aspirin: old drug, new uses and challenges J Gastroenterol Hepatol 26 3 2011 Mar 426 431
16. M.G. Geall, S.F. Phillips, and W.H.J. Summerskill Profile of gastric potential difference in man. Effects of aspirin, alcohol, bile, and endogenous acid Gastroenterology 58 1970 437 443
17. J.L. Wallace, and B.C. Chin Inflammatory mediators in gastrointestinal defense and injury Proc Soc Exp Biol Med 214 1997 192 203
18. B.K. Reuter, G. Cirino, and J.L. Wallace Markedly reduced intestinal toxicity of a diclofenac derivative Life Sci 55 1994 PL1 PL8
19. M.L. Capone, S. Tacconelli, M.G. Sciulli, M. Grana, E. Ricciotti, and P. Minuz Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects Circulation 109 2004 Mar 30 1468 1471
20. M.L. Capone, S. Tacconelli, L. Di Francesco, A. Sacchetti, M.G. Sciulli, and P. Patrignani Pharmacodynamic of cyclooxygenase inhibitors in humans Prostaglandins Other Lipid Mediat 82 2007 Jan 85 94
21. D.L. Simmons, R.M. Botting, and T. Hla Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol Rev 56 2004 387 437
22. W. Tomisato, S. Tsutsumi, T. Hoshino, H.J. Hwang, M. Mio, and T. Tsuchiya Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions Biochem Pharmacol 67 2004 575 585
23. S. Derry, and Y.K. Loke Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 2000 1183 1187
24. H.T. Sørensen, L. Mellemkjaer, W.J. Blot, G.L. Nielsen, F.H. Steffensen, and J.K. McLaughlin Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2000 Sep 2218 2224
25. J.P. Kelly, D.W. Kaufman, J.M. Jurgelon, J. Sheehan, R.S. Koff, and S. Shapiro Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product Lancet 348 9039 1996 Nov 23 1413 1416
26. A. Chowdhury, G. Ganguly, D. Chowdhury, A. Santra, J.D. Gupta, and T. Roy Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study Indian J Gastroenterol 20 2001 227 229
27. L.A. Garcia Rodriguez, S. Hernandez-Diaz, and F.J. de Abajo Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies Br J Clin Pharmacol 52 2001 563 571
28. I. Bjarnason, C. Scarpignato, K. Takeuchi, and K.D. Rainsford Determinants of the short term gastric damage caused by NSAIDs in man Aliment Pharmacol Ther 26 2007 95 106
29. R.L. Darling, J.J. Romero, E.J. Dial, J.K. Akunda, R. Langenbach, and L.M. Lichtenberger The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice Gastroenterology 127 2004 94 104
30. L.M. Lichtenberger, J.E. Richards, and B.A. Hills Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa Gastroenterology 88 1985 308 314
31. C.L. Campbell, S. Smyth, G. Montalescot, and S.R. Steinhubl Aspirin dose for the prevention of cardiovascular disease: a systematic review JAMA 297 2007 2018 2024
32. M.M. Cohen, and W.C. MacDonald Mechanism of aspirin injury to human gastroduodenal mucosa Prostaglandins Leukot Med 9 1982 241 255
33. D.L. Hogan, M.A. Ainsworth, and J.I. Isenberg Review article: gastroduodenal bicarbonate secretion Aliment Pharmacol Ther 8 1994 475 488
34. C. Johansson, A. Aly, R. Befrits, B. Smedfors, and A. Uribe Protection of the gastroduodenal mucosa by prostaglandins Scand J Gastroenterol Suppl 110 1985 41 48
35. M. Leivonen, P. Sipponen, and E. Kivilaakso Gastric changes in coronary-operated patients with low-dose aspirin Scand J Gastroenterol 27 1992 912 916
36. Y. Niv, A. Battler, G. Abuksis, E. Gal, B. Sapoznikov, and A. Vilkin Endoscopy in asymptomatic minidose aspirin consumers Dig Dis Sci 50 2005 78 80
37. F. Sopeña, and A. Lanas How to advise aspirin use in patients who need NSAIDs Curr Pharm Des 13 2007 2248 2260
38. C. Patrono, L.A. García Rodríguez, R. Landolfi, and C. Baigent Low-dose aspirin for the prevention of atherothrombosis N Engl J Med 353 2005 2373 2383
39. M.L. Capone, M.G. Sciulli, S. Tacconelli, M. Grana, E. Ricciotti, and G. Renda Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects J Am Coll Cardiol 45 2005 1295 1301
40. F. Catella-Lawson, M.P. Reilly, S.C. Kapoor, A.J. Cucchiara, S. DeMarco, and B. Tournier Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 345 2001 1809 1817
41. B. Simon, H. Elsner, and P. Muller Protective effect of omeprazol against low dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjects Arzneimittelforshung 45 1995 701 703
42. P. Muller, W. Fuchs, and B. Simon Studies on protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic. An endoscopic controlled double-blind study Arzneimittelforshung 47 1997 758 760
43. J. Hart, C.J. Hawkey, A. Lanas, J. Naesdal, N.J. Talley, and A.B. Thomson Predictors of gastroduodenal erosions in patients taking low-dose aspirin Aliment Pharmacol Ther 31 1 2010 Jan 143 149
44. L. Laine, E.S. Maller, C. Yu, H. Quan, and T. Simon Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial Gastroenterology 127 2 2004 Aug 395 402
45. F.K. Chan, K.F. To, J.C. Wu, M.Y. Yung, W.K. Leung, and T. Kwok Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial Lancet 359 9300 2002 Jan 5 9 13
46. A. Moore, I. Bjarnason, B. Cryer, L. Garcia-Rodriguez, L. Goldkind, and A. Lanas Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm Clin Gastroenterol Hepatol 7 11 2009 Nov 1156 1163
47. P.J. Fortun, and C.J. Hawkey Nonsteroidal antiinflammatory drugs and the small intestine Curr Opin Gastroenterol 21 2005 169 175
48. R.A. Moore, S. Derry, and H.J. McQuay Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes Arthritis Res Ther 10 2008 R7
49. E. Smecuol, M.I. Pinto Sanchez, A. Suarez, J.E. Argonz, E. Sugai, and H. Vazquez Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment Clin Gastroenterol Hepatol 7 5 2009 May 524 529
50. S. Hernández-Díaz, and L.A. García Rodríguez Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications BMC Med 4 2006 Sep 20 22
51. A. Lanas, E. Bajador, P. Serrano, J. Fuentes, S. Carreño, and J. Guardia Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding N Engl J Med 343 2000 834 839
52. A. Lanas, J. Fuentes, R. Benito, P. Serrano, E. Bajador, and R. Sainz Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin Aliment Pharmacol Ther 16 2002 779 786
53. A. Lanas, P. Wu, J. Medin, and E.J. Mills Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis Clin Gastroenterol Hepatol 9 9 2011 Sep 762 768
54. G.E. Vist, K.B. Hagen, P.J. Devereaux, D. Bryant, D.T. Kristoffersen, and A.D. Oxman Systematic review to determine whether participation in a trial influences outcome BMJ 330 2005 1175
55. P. Serrano, A. Lanas, M.T. Arroyo, and I.J. Ferreira Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Aliment Pharmacol Ther 16 2002 1945 1951
56. L. Laine, and K. McQuaid Bleeding complications related to aspirin dose Am J Cardiol 96 7 2005 Oct 1 1035 1036
57. CURRENT-OASIS 7 Investigators, S.R. Mehta, J.P. Bassand, S. Chrolavicius, R. Diaz, J.W. Eikelboom, and K.A. Fox Dose comparisons of clopidogrel and aspirin in acute coronary syndromes N Engl J Med 363 10 2010 Sep 2 930 942
58. A.S. Taha, W.J. Angerson, R. Prasad, C. McCloskey, D. Gilmour, and C.G. Morran Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs Aliment Pharmacol Ther 28 7 2008 Oct 1 878 885
59. J.W. Hoftiezer, G.R. Silvoso, M. Burks, and K.J. Ivey Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man Lancet 2 8195 pt 1 1980 Sep 20 609 612
60. C. Sostres, C. Gargallo, and A. Lanas Drug-related damage of the ageing gastrointestinal tract Best Pract Res Clin Gastroenterol 23 6 2009 849 860
61. A. Lanas, M.C. Sekar, and B.I. Hirschowitz Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding Gastroenterology 103 1992 862 869
62. M.J. Langman, L. Morgan, and A. Worrall Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage Br Med J (Clin Res Ed) 290 6465 1985 Feb 2 347 349
63. C.M. Wilcox, L.N. Alexander, G.A. Cotsonis, and W.S. Clark Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding Dig Dis Sci 42 1997 990 997
64. A. Lanas, P. Serrano, E. Bajador, F. Esteva, R. Benito, and R. Sainz Evidence of aspirin use in both upper and lower gastrointestinal perforation Gastroenterology 112 1997 683 689
65. A. Lanas, M.A. Perez-Aisa, F. Feu, J. Ponce, E. Saperas, and S. Santolaria A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use Am J Gastroenterol 100 2005 1685 1693
66. L.L. Strate, Y.L. Liu, E.S. Huang, E.L. Giovannucci, and A.T. Chan Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding Gastroenterology 140 5 2011 May 1427 1433 [Epub 2011 Feb 12]
67. E. Huang, L.L. Strate, W. Ho, S.S. Lee, and A.T. Chan Long-term use of aspirin and the risk of gastrointestinal bleeding in a prospective, population-based cohort Gastroenterology 138 Suppl. 1 2010 475e
68. Y. Zhao, and W. Encinosa Hospitalizations for gastrointestinal bleeding 1998 and 2006 HCUP Statistical Brief #65 December 2008 Agency for Healthcare Research and Quality Rockville, MD http://www.hcup-us.ahr.gov/reports/ statbriefs/sb65.pdf
69. A. Lanas, L.A. García-Rodríguez, M. Polo-Tomás, M. Ponce, I. Alonso-Abreu, and M.A. Perez-Aisa Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice Am J Gastroenterol 104 7 2009 Jul 1633 1641
70. F.K. Chan, N.S. Abraham, J.M. Scheiman, and L. Laine First International Working Party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents Am J Gastroenterol 103 2008 2908 2918
71. M.A. Pérez-Aisa, D. Del Pino, M. Siles, and A. Lanas Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection Aliment Pharmacol Ther 21 2005 65 67
72. G.I. Leontiadis, and C.W. Howden The role of proton pump inhibitors in the management of upper gastrointestinal bleeding Gastroenterol Clin North Am 38 2009 199 213
73. A.N. Barkun, M. Martel, Y. Toubouti, E. Rahme, and M. Bardou Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses Gastrointest Endosc 69 2009 786 799
74. A. Lanas Editorial: upper GI bleeding-associated mortality: challenges to improving a resistant outcome Am J Gastroenterol 105 1 2010 Jan 90 92
75. A. Shiotani, T. Sakakibara, M. Nomura, Y. Yamanaka, R. Nishi, and H. Imamura Aspirin-induced peptic ulcer and genetic polymorphisms J Gastroenterol Hepatol 25 Suppl. 1 2010 May S31 S34
76. S. Fiorucci, L. Santucci, P. Gresele, R.M. Faccino, P. Del Soldato, and A. Morelli Gastrointestinal safety of NO-aspirin (NCX 4016) in healthy human volunteers: a proof of concept endoscopic study Gastroenterology 124 2003 600 607
77. P.J. Goddard, and L.M. Lichtenberger In vitro recovery of canine gastric mucosal surface hydrophobicity and potential difference after aspirin damage Dig Dis Sci 40 1995 1357 1359
78. B. Cryer, D.L. Bhatt, F.L. Lanza, J.F. Dong, L.M. Lichtenberger, and U.K. Marathi Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial Am J Gastroenterol 106 2011 272 277